Detalles de la búsqueda
1.
Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus.
Br J Clin Pharmacol
; 81(5): 908-17, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26648084
2.
Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.
Arthritis Rheum
; 65(4): 1011-21, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23400715
3.
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis.
Arthritis Res Ther
; 26(1): 117, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38845046
4.
Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus.
J Transl Autoimmun
; 5: 100152, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35517914
5.
Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study.
ACR Open Rheumatol
; 4(10): 903-911, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35899378
6.
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Ann Rheum Dis
; 70(11): 1905-13, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21798883
7.
Investigation of Potential Drug-Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis.
Clin Drug Investig
; 40(9): 827-838, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591978
8.
Examining the relationship between bone mineral density and fracture risk reduction during pharmacologic treatment of osteoporosis.
Pharmacotherapy
; 26(1): 104-14, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16506352
9.
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.
Clin Pharmacol Drug Dev
; 5(4): 259-68, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27310327
10.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.
Clin Pharmacol Drug Dev
; 5(5): 408-25, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27410490
11.
Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
J Pain
; 6(6): 392-9, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15943961
12.
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.
Arthritis Res Ther
; 13(5): R177, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22029963
13.
Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
Arthritis Rheum
; 60(2): 335-44, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19180516
Resultados
1 -
13
de 13
1
Próxima >
>>